Botanix Pharmaceuticals Limited (ASX:BOT)
Australia · Delayed Price · Currency is AUD 0.0120
-0.0010 (-7.69%)
Oct 22, 2026, 10:31 AM AEDT
Botanix Pharmaceuticals Market Cap
Botanix Pharmaceuticals has a market cap or net worth of 32.84 million as of October 21, 2026. It is the 35,962nd most valuable company in the world and the 923rd biggest in Australia. Its market cap has decreased by 89.25% in one year.
Market Cap
32.84M
Enterprise Value
-2.88M
Revenue
33.80M
Global Rank
Country Rank
#923 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since July 15, 2016, Botanix Pharmaceuticals's market cap has increased from 12.26M to 32.84M, an increase of 167.76%. That is a compound annual growth rate of 10.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 35.58M | -86.61% |
| Dec 31, 2025 | 265.72M | -66.39% |
| Dec 31, 2024 | 790.67M | 168.97% |
| Dec 29, 2023 | 293.96M | 367.07% |
| Dec 30, 2022 | 62.94M | 15.49% |
| Dec 31, 2021 | 54.50M | -55.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arovella Therapeutics | 60.44M |
| Avecho Biotechnology | 54.09M |
| Entropy Neurodynamics | 53.91M |
| Amplia Therapeutics | 41.06M |
| Immutep | 33.90M |
| Neurotech International | 29.09M |
| Nexsen | 28.03M |
| NeuroScientific Biopharmaceuticals | 22.60M |